Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 14, n. 2, p. 51–74, 2013. DOI: 10.7175/fe.v14i2.651. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/651. Acesso em: 15 feb. 2026.